When someone is treated for cancer, they often thank their doctors, their nurses, and the other members of the healthcare team —and rightly so, since these profes- sionals work diligently and compas- sionately to provide the very best care. But there are other people who also deserve our thanks, many of whom patients never meet.
They are the scientists who conducted the research that led to today’s more effective treatments. The staff and donors who supported those investiga- tors. And the patients who participated in clinical trials of novel treatment ap- proaches that are now a part of stan- dard cancer care.
More people are living with or after cancer today than ever before, thanks to better therapies. More cancers are diagnosed early, when they are more curable, thanks to better screening tools. And more people are able to go about their regular lives during cancer treatment, thanks to better supportive therapies.
The NYU Cancer Institute at NYU Langone Medical Center recognizes that research is not just important, but absolutely vital to making such prog- ress against cancer. In this issue, we profile four young investigators who are not only sharp and dedicated, but are creative thinkers who can see the “big picture” about how cancer develops and spot promising new avenues of study. They represent our investment in the future of cancer care.
But effective treatment isn’t just about better drugs, radiation, or surgery. In this issue, you can also read about the services our Integrative Health Program offers to help relieve pain and other symptoms in patients receiving cancer treatment, from the moment of their diagnosis and throughout their care.
Such support is a hallmark of our ap- proach to patient care. I’d also like to recognize a different kind of support: contributions that make it possible to do the pioneering work we do. I’d like to thank all those who participated in our 2013 annual Gala, which raised $1.7 million. Equally important are the contributions that come from former patients and their families, alumni of the NYU School of Medicine, and oth- ers who choose to include us in their estate planning. You can read in this issue about how to support The Cancer Institute through such vehicles, and our planning giving specialists are ready to guide you through the process every step of the way.
To all who have supported The Cancer Institute and to those considering doing so, I thank you for your interest in our work and look forward with you to a brighter future for people with cancer and their families.
William L. Carroll, MD
The Julie and Edward J. Minskoff Professor of Pediatrics
Professor of Pathology
Director, NYU Cancer Institute